|
|
Article: OTHER NEWS TO NOTE.
- Article from:
- BIOWORLD Today
- Article date:
- December 27, 2000
CopyrightCOPYRIGHT 2000 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
AltaRex Corp., of Waltham, Mass., and Dompe Farmaceutici S.p.A., of Milan, Italy, said they closed Dompe's private placement purchase of about 3.5 million shares of AltaRex stock at C$2.20 (US$1.45) per share for net proceeds of C$7.75 million. Dompe now owns about 16 percent of AltaRex's common stock. Proceeds will be used to advance development of AltaRex's lead products, OvaRex and BrevaRex MAbs.
Aurora Biosciences Corp., of San Diego, said the third and final component of its ultra-high-throughput screening system (UHTSS) has been accepted and validated by Bristol-Myers Squibb Pharmaceutical Research Institute in Wallingford, Conn. The UHTSS Platform ...